Valbenazine significantly reduced involuntary movements associated with tardive dyskinesia in patients with primary mood disorders, at both 6 weeks and 48 weeks after beginning the treatment, according to a published analysis.
People prescribed antidepressants were 21% more likely to gain weight than people not prescribed the medication class, researchers found in a study published online in BMJ.
In a study of more than 91,000 people, which factor was the strongest predictor of conversion from unipolar depression to bipolar disorder? Get the answer and more information here.
Night-eating syndrome (NES) is more common among people with bipolar disorder (BD) than in the general population, new findings suggest.
NEW YORK CITY—The antidepressant patch selegiline reduced anxiety, depression, and somatic complaints in responders with bipolar I depression and borderline personality disorder in a small trial.
A new in vitro study may help explain how valproate (VPA) exposure in the womb can lead to adverse fetal and childhood outcomes.
There is a fracturing upon initial diagnosis with a mental illness. It is a schism that grows and begins to separate a person not only from the present moment, but also from his or her past.
I have destroyed the closest and most intimate relationships in my life. I have done this with actions while I was acutely symptomatic with my bipolar I disorder, while I engaged in active addiction, and while I was stone-cold sober. To move into a recovery mode meant the reconstruction of most of my personal relationships.
For a long time after my first manic episode, I feared my emotions. The mania I experience is devastating. It is like having lightning in your veins. It is a miserable state of existence to associate bliss with sickness, joy with disease.
Terence Ketter, MD, Professor of Psychiatry and Chief of the Bipolar Clinic at Stanford University, discusses the benefits and harms of anticonvulsants for bipolar disorder.
Terence Ketter, MD, Professor of Psychiatry and Chief of the Bipolar Clinic at Stanford University, discusses highlights from his symposium presentation at the American Psychiatric Association meeting. Dr.